Skip to main content
IVVD
NASDAQ Life Sciences

Invivyd Completes Enrollment in Upsized Phase 3 COVID Antibody Trial, Results Expected Q3

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$1.17
Mkt Cap
$335.852M
52W Low
$0.483
52W High
$3.07
52W Position info
142% above low
Off High info
62% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

IVVD has more than doubled off its 52-week low of $0.483.

Summary

Invivyd has completed enrollment for its Phase 3 DECLARATION clinical trial of VYD2311, an investigational COVID-19 antibody. The trial was previously upsized by approximately 500 subjects to increase statistical power, as announced in April. This milestone moves the company closer to top-line results, which are still expected in late Q3 2026. VYD2311 is a critical pipeline asset for Invivyd, especially following its recent Q1 net loss and 'going concern' warning.

At the time of this announcement, IVVD was trading at $1.17 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $335.9M. The 52-week trading range was $0.48 to $3.07. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

IVVD - Latest Insights

IVVD
Sep 29, 2026, 7:26 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.9635
Real-time Price: $0.620 info
Change: -$0.3435 (-36%) info
Market Cap: $175.735M info
IVVD
Sep 29, 2026, 7:07 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $1.16
Real-time Price: $0.620 info
Change: -$0.5398 (-47%) info
Market Cap: $175.735M info
IVVD
Sep 01, 2026, 7:10 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.9303
Real-time Price: $0.620 info
Change: -$0.3103 (-33%) info
Market Cap: $175.735M info
IVVD
Aug 13, 2026, 4:25 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $0.666
Real-time Price: $0.620 info
Change: -$0.046 (-7%) info
Market Cap: $175.735M info
IVVD
Aug 13, 2026, 4:14 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.661
Real-time Price: $0.620 info
Change: -$0.041 (-6%) info
Market Cap: $175.735M info